Institutional investors purchased a net $1.0 million shares of PBMD during the quarter ended December 2016, and now own 4.45% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
SABBY CAPITAL LLC Bought 962.8 Thousand shares of Prima BioMed Ltd
KCG AMERICAS LLC Bought 34.6 Thousand shares of Prima BioMed Ltd
CITADEL ADVISORS LLC Bought 10.3 Thousand shares of Prima BioMed Ltd